PURE Bioscience (OTCMKTS:PURE) is scheduled to be releasing its earnings data after the market closes on Thursday, December 14th. Analysts expect PURE Bioscience to post earnings of ($0.02) per share for the quarter.

PURE Bioscience (OTCMKTS PURE) opened at $1.00 on Thursday. PURE Bioscience has a 52-week low of $0.75 and a 52-week high of $1.36.

Separately, ValuEngine raised PURE Bioscience from a “sell” rating to a “hold” rating in a research report on Wednesday, November 29th.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another website, it was copied illegally and reposted in violation of US and international trademark and copyright legislation. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/12/07/pure-bioscience-pure-scheduled-to-post-quarterly-earnings-on-thursday.html.

PURE Bioscience Company Profile

PURE Bioscience, Inc is focused on developing and commercializing antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. The Company’s technology platform is based on stabilized ionic silver and its products contain silver dihydrogen citrate (SDC).

Earnings History for PURE Bioscience (OTCMKTS:PURE)

Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.